UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Journal of the American Geriatrics Society (JAGS), 2008-07, Vol.56 (7), p.1333-1341

2008

Volltextzugriff (PDF)

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

Schizophrenia research, 2005-09, Vol.77 (2), p.215-227

2005

Volltextzugriff (PDF)

Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation

Neuropsychopharmacology (New York, N.Y.), 2006-11, Vol.31 (11), p.2505-2513

2006

Volltextzugriff (PDF)

A model of anticholinergic activity of atypical antipsychotic medications

Schizophrenia research, 2006-12, Vol.88 (1), p.63-72

2006

Volltextzugriff (PDF)

Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression

The American journal of geriatric psychiatry, 2008-01, Vol.16 (1), p.21-30

2008

Volltextzugriff (PDF)

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder

The journal of clinical psychiatry, 2006-08, Vol.67 (8), p.1194-1203

2006

Volltextzugriff (PDF)

Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam

The journal of clinical psychiatry, 2004-03, Vol.65 (3), p.386-394

2004

Volltextzugriff (PDF)

Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study

The journal of clinical psychiatry, 2007-08, Vol.68 (8), p.1186-1194

2007

Volltextzugriff (PDF)

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

Schizophrenia research, 2006-07, Vol.85 (1), p.254-265

2006

Volltextzugriff (PDF)

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial

BMC psychiatry, 2006-10, Vol.6 (1), p.45-45, Article 45

2006

Volltextzugriff (PDF)

Risperidone in the Treatment of Psychosis of Alzheimer Disease: Results From a Prospective Clinical Trial

The American journal of geriatric psychiatry, 2006-03, Vol.14 (3), p.280-291

2006

Volltextzugriff (PDF)

Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.233-240

2006

Volltextzugriff (PDF)

Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial

The international journal of neuropsychopharmacology, 2005-09, Vol.8 (3), p.427-438

2005

Volltextzugriff (PDF)

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

European psychiatry, 2004-06, Vol.19 (4), p.219-225

2004

Volltextzugriff (PDF)

Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia

Schizophrenia research, 2005-09, Vol.77 (2), p.119-128

2005

Volltextzugriff (PDF)

Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone

The journal of clinical psychiatry, 2004-09, Vol.65 (9), p.1197-1210

2004

Volltextzugriff (PDF)

Risperidone for treatment-refractory major depressive disorder: a randomized trial

Annals of internal medicine, 2007-11, Vol.147 (9), p.593

2007

Volltextzugriff (PDF)

New-Onset Tardive Dyskinesia in Patients With First-Episode Psychosis Receiving Risperidone or Haloperidol

The American journal of psychiatry, 2006-05, Vol.163 (5), p.938-939

2006

Volltextzugriff (PDF)

Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: A secondary analysis of a randomized, double-blind, placebo-controlled trial

Journal of affective disorders, 2009-11, Vol.118 (1), p.139-146

2009

Volltextzugriff (PDF)

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder

Current medical research and opinion, 2007-11, Vol.23 (11), p.2815-2822

2007

Volltextzugriff (PDF)

An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: Results from a long-term study

Schizophrenia research, 2005-09, Vol.77 (2), p.129-139

2005

Volltextzugriff (PDF)

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine

The journal of clinical psychiatry, 2004-12, Vol.65 (12), p.1708-1714

2004

Volltextzugriff (PDF)

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

Annals of general psychiatry, 2007-01, Vol.6 (1), p.3-3, Article 3

2007

Volltextzugriff (PDF)

Patient-based and clinician-based support for the remission criteria in schizophrenia

International clinical psychopharmacology, 2007-01, Vol.22 (1), p.51

2007

Volltextzugriff (PDF)

Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD

Child and adolescent psychiatry and mental health, 2007-06, Vol.1 (1), p.3-3, Article 3

2007

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Psychiatry
(34)
Female
(29)
Male
(29)
Risperidone - Therapeutic Use
(26)
Antipsychotic Agents - Therapeutic Use
(25)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Schizophrenia - Drug Therapy
(23)
Adult
(22)
Middle Aged
(22)
Psychology. Psychoanalysis. Psychiatry
(22)
Double-Blind Method
(20)
Pharmacology. Drug Treatments
(19)
Psychopharmacology
(18)
Neuropharmacology
(17)
Psycholeptics: Tranquillizer, Neuroleptic
(17)
Psychotic Disorders - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation

A model of anticholinergic activity of atypical antipsychotic medications

Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder

Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam

Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial

Risperidone in the Treatment of Psychosis of Alzheimer Disease: Results From a Prospective Clinical Trial

Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone

Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia

Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone

Risperidone for treatment-refractory major depressive disorder: a randomized trial

New-Onset Tardive Dyskinesia in Patients With First-Episode Psychosis Receiving Risperidone or Haloperidol

Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: A secondary analysis of a randomized, double-blind, placebo-controlled trial

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder

An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: Results from a long-term study

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

Patient-based and clinician-based support for the remission criteria in schizophrenia

Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD

Suchergebnisse filtern